Reproductive genome editing interventions are therapeutic, sometimes

被引:5
|
作者
Palacios-Gonzalez, Cesar [1 ]
机构
[1] Univ Oxford, Uehiro Ctr Pract Eth, Fac Philosophy, 16-17 St Ebbes St, Oxford OX1 1PT, England
基金
英国惠康基金;
关键词
assisted reproduction; CRISPR; gene editing; genome editing; germline editing; therapy; PERSON-REGARDING REASONS; GENETIC THERAPY; IDENTITY;
D O I
10.1111/bioe.12846
中图分类号
B82 [伦理学(道德学)];
学科分类号
摘要
In this paper I argue that some human reproductive genome editing interventions can be therapeutic in nature, and thus that it is false that all such interventions just create healthy individuals. I do this by showing that the conditions established by a therapy definition are met by certain reproductive genome editing interventions. I then defend this position against two objections: (a) reproductive genome editing interventions do not attain one of the two conditions for something to be a therapy, and (b) some reproductive genome editing interventions are therapeutic but in a nonstandard way. In the Conclusion I call for a more nuanced discussion of the nature of reproductive genome editing interventions.
引用
收藏
页码:557 / 562
页数:6
相关论文
共 50 条
  • [1] Genome editing of therapeutic cells
    Kim, Seokjoong
    Lee, Jaeyoung
    Lee, Kangin
    Song, Dong Woo
    TISSUE ENGINEERING PART A, 2022, 28 : 97 - 97
  • [2] Therapeutic genome editing: regulatory horizons
    Philip A. Hines
    Eleonora Agricola
    Jordi Llinares Garcia
    Laurence O’Dwyer
    Ralf Herold
    Nature Reviews Drug Discovery, 2022, 21 : 1 - 2
  • [3] A therapeutic genome editing primer for cardiologist
    Caiazza, Martina
    Masarone, Daniele
    Limongelli, Giuseppe
    CARDIOGENETICS, 2018, 8 (01) : 9 - 12
  • [4] Genome Editing Techniques and Their Therapeutic Applications
    Calos, M. P.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (01) : 42 - 51
  • [5] Therapeutic genome editing: regulatory horizons
    Hines, Philip A.
    Agricola, Eleonora
    Llinares Garcia, Jordi
    O'Dwyer, Laurence
    Herold, Ralf
    NATURE REVIEWS DRUG DISCOVERY, 2022, 21 (01) : 1 - 2
  • [6] The Daunting Economics of Therapeutic Genome Editing
    Wilson, Ross C.
    Carroll, Dana
    CRISPR JOURNAL, 2019, 2 (05): : 280 - 284
  • [7] Therapeutic Genome Editing in Cardiovascular Diseases
    German, David M.
    Mitalipov, Shoukhrat
    Mishra, Anusha
    Kaul, Sanjiv
    JACC-BASIC TO TRANSLATIONAL SCIENCE, 2019, 4 (01): : 122 - 131
  • [8] Therapeutic Genome Editing and In Vivo Delivery
    Amanda Catalina Ramirez-Phillips
    Dexi Liu
    The AAPS Journal, 23
  • [9] Therapeutic application of genome editing in dyslipidemia
    Whittaker, Madelynn N.
    Musunuru, Kiran
    CURRENT OPINION IN LIPIDOLOGY, 2022, 33 (02) : 133 - 138
  • [10] Therapeutic genome editing in cardiovascular diseases
    Wu, Joseph C. (joewu@stanford.edu), 1600, Elsevier B.V. (168):